Dr. Robert Layne Kruse, MD, PhD

Dr. Kruse practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Kruse's NPI, 1902399421, was assigned on June 9, 2018. Dr. Kruse graduated from Baylor College Of Medicine in 2018. Dr. Kruse holds Texas license T9158.

Dr. Kruse's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Kruse's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kruse practices. Vendor and product names are available with a free account.

Clinical pathology is Dr. Kruse's primary specialty in the NPI Registry, under taxonomy code 207ZC0006X. Dr. Kruse is board certified in blood banking/transfusion medicine by the American Board of Pathology. Dmand AI has Dr. Kruse's licenses on file in 2 states: Texas and Massachusetts.

CMS data shows 21 Medicare services from Dr. Kruse across 1 procedure code in 2024, for 26 Medicare patients. Medicare paid $794 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Kruse in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kruse's median patient age at 44, with 85% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Kruse for performance year 2024, reported as part of a group. Dr. Kruse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Kruse, published from 2014 to 2022. 2021 was the busiest year, with 6. The most frequent topics are Genetic Therapy, Hepatitis B Surface Antigens and Receptors, Antigen, T-Cell. Dr. Kruse's most frequent co-authors are Yuting Huang, MD, PhD, Evan Martin Bloch, MD and Vivek Kumbhari, MD.

CMS Open Payments shows 2 general payments to Dr. Kruse from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $115.

Dr. Kruse graduated from Baylor College Of Medicine in 2018.

Dr. Kruse is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.